Literature DB >> 2115910

Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates.

K Rasmussen1, D B Beitner-Johnson, J H Krystal, G K Aghajanian, E J Nestler.   

Abstract

We have compared the time course of the behavioral manifestations of opiate withdrawal to the in vivo activity of locus coeruleus (LC) neurons and to increases in the levels of G-proteins, adenylate cyclase, and cAMP-dependent protein kinase known to occur in the LC in opiate-dependent animals. Rats were given morphine by daily subcutaneous implantation of morphine pellets for 5 d. On the sixth day, morphine withdrawal was induced by subcutaneous administration of naltrexone, an opiate receptor antagonist, with additional doses given 6 and 24 hr later, conditions that resulted in sustained, maximal levels of withdrawal over the duration of the experiment. We found a striking parallel between the time courses of the behavioral signs and the increased activity of LC neurons during withdrawal, both of which appeared to follow 2 phases. There was an early, rapid phase, during which withdrawal signs and increased LC activity became most pronounced within 15-30 min after naltrexone administration, and then recovered rapidly by over 50% within 4 hr of withdrawal. Subsequently, there was a slower phase, during which the persisting withdrawal signs and elevated LC activity remained roughly constant from 4 to 24 hr and did not recover completely until after 72 hr of continuous withdrawal. Adenylate cyclase and cAMP-dependent protein kinase activities in isolated LC subcellular fractions, both elevated in dependent animals, recovered to control levels after 6 hr of withdrawal, in parallel with the rapid phase of withdrawal. Levels of G1 and Go, also elevated in dependent animals, remained only slightly elevated at 6 hr and returned to normal by 24 hr. Taken together, these data suggest that increased neuronal activity in the LC is associated temporally with the behavioral morphine withdrawal syndrome and that increased levels of G-proteins and an up-regulated cAMP system may contribute to the early withdrawal activation of these neurons.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115910      PMCID: PMC6570391     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  91 in total

1.  Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.

Authors:  D H Wolf; S Numan; E J Nestler; D S Russell
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

Review 2.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

3.  Hyperbaric Oxygen Attenuates Withdrawal Symptoms by Regulating Monoaminergic Neurotransmitters and NO Signaling Pathway at Nucleus Accumbens in Morphine-Dependent Rats.

Authors:  Chunxia Chen; Qiuping Fan; Zhihuan Nong; Wan Chen; Yaoxuan Li; Luying Huang; Daorong Feng; Xiaorong Pan; Shengyong Lan
Journal:  Neurochem Res       Date:  2018-01-08       Impact factor: 3.996

4.  Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.

Authors:  C H Brown; G Munro; N P Murphy; G Leng; J A Russell
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

5.  Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.

Authors:  Debora Steiner; Tomer Avidor-Reiss; Ester Schallmach; Elena Butovsky; Nirit Lev; Zvi Vogel
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

6.  CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.

Authors:  S B Lane-Ladd; J Pineda; V A Boundy; T Pfeuffer; J Krupinski; G K Aghajanian; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

7.  Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies.

Authors:  Venetia Zachariou; Rongjian Liu; Quincey LaPlant; Guanghua Xiao; William Renthal; Guy C Chan; Daniel R Storm; George Aghajanian; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2008-01-28       Impact factor: 13.382

8.  Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice.

Authors:  V A Boundy; S J Gold; C J Messer; J Chen; J H Son; T H Joh; E J Nestler
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system.

Authors:  Arati Kreibich; Beverly A S Reyes; Andre L Curtis; Laurel Ecke; Charles Chavkin; Elisabeth J Van Bockstaele; Rita J Valentino
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

10.  Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.

Authors:  Meritxell Llorca-Torralba; Fuencisla Pilar-Cuéllar; Lidia Bravo; Cristina Bruzos-Cidon; María Torrecilla; Juan A Mico; Luisa Ugedo; Emilio Garro-Martínez; Esther Berrocoso
Journal:  Mol Neurobiol       Date:  2018-10-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.